The Cannabist Company Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA13765Y1034
CAD
0.06
-0.01 (-15.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.37 M

Shareholding (Sep 2025)

FII

0.08%

Held by 4 FIIs

DII

99.92%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 37 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.93

stock-summary
Return on Equity

103.25%

stock-summary
Price to Book

-0.18

Revenue and Profits:
Net Sales:
120 Million
(Quarterly Results - Jun 2025)
Net Profit:
-107 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.62%
0%
-47.62%
6 Months
-57.69%
0%
-57.69%
1 Year
-31.25%
0%
-31.25%
2 Years
-91.41%
0%
-91.41%
3 Years
-93.04%
0%
-93.04%
4 Years
-98.37%
0%
-98.37%
5 Years
-99.32%
0%
-99.32%

The Cannabist Company Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
23.52%
EBIT Growth (5y)
7.51%
EBIT to Interest (avg)
-2.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-4.87
Sales to Capital Employed (avg)
1.54
Tax Ratio
50.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.37
EV to EBIT
-8.20
EV to EBITDA
-116.09
EV to Capital Employed
2.21
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-26.99%
ROE (Latest)
Negative BV

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.08%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -4.78% vs -6.62% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -131.82% vs 40.08% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "119.50",
          "val2": "125.50",
          "chgp": "-4.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.60",
          "val2": "1.00",
          "chgp": "-1,160.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "21.30",
          "val2": "14.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.70",
          "val2": "-12.50",
          "chgp": "105.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-107.10",
          "val2": "-46.20",
          "chgp": "-131.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-183.40%",
          "val2": "-91.10%",
          "chgp": "-9.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -8.94% vs 3.62% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 38.78% vs 57.14% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "628.40",
          "val2": "690.10",
          "chgp": "-8.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.60",
          "val2": "58.20",
          "chgp": "-31.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "56.80",
          "val2": "74.10",
          "chgp": "-23.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-44.80",
          "val2": "-122.70",
          "chgp": "63.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-144.00",
          "val2": "-235.20",
          "chgp": "38.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-43.70%",
          "val2": "-38.40%",
          "chgp": "-0.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary

Jun'25
Mar'25
Change(%)
Net Sales
119.50
125.50
-4.78%
Operating Profit (PBDIT) excl Other Income
-10.60
1.00
-1,160.00%
Interest
21.30
14.20
50.00%
Exceptional Items
0.70
-12.50
105.60%
Consolidate Net Profit
-107.10
-46.20
-131.82%
Operating Profit Margin (Excl OI)
-183.40%
-91.10%
-9.23%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -4.78% vs -6.62% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -131.82% vs 40.08% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
628.40
690.10
-8.94%
Operating Profit (PBDIT) excl Other Income
39.60
58.20
-31.96%
Interest
56.80
74.10
-23.35%
Exceptional Items
-44.80
-122.70
63.49%
Consolidate Net Profit
-144.00
-235.20
38.78%
Operating Profit Margin (Excl OI)
-43.70%
-38.40%
-0.53%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -8.94% vs 3.62% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 38.78% vs 57.14% in Dec 2023

stock-summaryCompany CV
About The Cannabist Company Holdings, Inc. stock-summary
stock-summary
The Cannabist Company Holdings, Inc.
Pharmaceuticals & Biotechnology
Columbia Care Inc is a provider of cannabis-based health and wellness solutions. The Company is engaged cultivating, manufacturing and providing medical and adult use cannabis products and related services with licenses in over 18 the United States jurisdictions and the European Union (EU). The Company operates over 108 facilities including 81 dispensaries and 27 cultivation and manufacturing facilities. The Company operates as the original providers of medical cannabis in the United States and continues to deliver a patient-centered medicinal cannabis operation. The company offers products spanning flower, edibles, oils, and tablets, and manufactures brands including Seed & Strain, Amber and Platinum Label Cannabidiol (CBD) products.
Company Coordinates stock-summary
Company Details
680 Fifth Ave., 24th Floor , NEW YORK NY : 10019
stock-summary
Tel: 1 416 86973681 121 2710915
stock-summary
Registrar Details